John Temperato - 21 Feb 2022 Form 4 Insider Report for 9 METERS BIOPHARMA, INC. (NMTR)

Role
Chief Executive Officer, Director
Signature
/s/ Bethany Sensenig, as power of attorney
Issuer symbol
NMTR
Transactions as of
21 Feb 2022
Transactions value $
$0
Form type
4
Filing time
23 Feb 2022, 15:15:41 UTC
Previous filing
19 Nov 2021
Next filing
04 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NMTR Stock Option (Right to Buy) Award $0 +2.48M $0.00 2.48M 21 Feb 2022 Common stock 2.48M $0.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of these shares shall be deemed vested and exercisable on February 21, 2023 with the remainder vesting in equal monthly installments over the next 36 months, such that the option shall be fully vested on February 21, 2026, subject to the executive's continued service with the Company through each applicable vesting date.

Remarks:

EX-24: Power of Attorney